Records containing: Idiopathic Pulmonary Fibrosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-08-14A Phase Ib, Randomised, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of an Intravenous Monoclonal Antibody (mAb) After Single Ascending Doses in Subjects Affected by Idiopathic Pulmonary Fibrosis.
-
CLINICAL_TRIALS study record update · 2025-08-06A Phase 1b, Open-label Study of PIPE-791 to Determine Brain and Lung Lysophosphatidic Acid Receptor 1 (LPA1) Occupancy, by [18F] PIPE-497 PET Imaging in Healthy Volunteers, Volunteers With Progressive Multiple Sclerosis, and Volunteers With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2025-08-05A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DWN12088 in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2025-08-01A Randomized, Double-blind, Dose-ranging, Placebo-controlled Study to Evaluate the Efficacy and Safety of Bexotegrast (PLN-74809) for the Treatment of Idiopathic Pulmonary Fibrosis (BEACON-IPF)
-
CLINICAL_TRIALS study record update · 2025-07-31A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation, Safety, Tolerability and Pharmacodynamic Biomarker Study of Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03) in Recently Diagnosed, Treatment Naïve Subjects With IPF
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-07-28Assessment of the Dose Reduction and Discontinuation Associated With Anti-Fibrotic Medications in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2025-07-24PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort
-
CLINICAL_TRIALS study record update · 2025-07-24A Mobile Health Exercise Prescription to Enhance Effectiveness of Antifibrotic Therapy in Patients With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2025-07-14Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2025-07-09Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2025-07-02Evaluating the Diagnostic Performance of High-Resolution Computed Tomography (HRCT) in Detecting Idiopathic Pulmonary Fibrosis (IPF) in Suspected Cases
-
CLINICAL_TRIALS study record update · 2025-06-27A Randomized, Double-Blind, Placebo-Controlled, Parallel, 4-Arm Dose Ranging Study of the Safety and Efficacy of Nalbuphine Extended-Release Tablets (NAL ER) for the Treatment of Cough in Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2025-06-25The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study
-
CLINICAL_TRIALS study record update · 2025-06-24Observational, Multicentre, Prospective, Real-world Post-authorization Safety Study Describing the Achievement of Nintedanib-associated DIArrhoea Control After 12 Weeks of Follow-up in Patients With Idiopathic puLmonary FIBrosis (IPF) and Progressive Pulmonary Fibrosis (Other Than IPF) in Spain: the DIALFIB Study
-
CLINICAL_TRIALS study record update · 2025-06-22Long Term, Single-arm, Open-label Extension Study of the MUSIC Study to Assess the Safety and Tolerability of Macitentan in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2025-06-13Clinical Research on the Improvement of Exercise Endurance in Idiopathic Pulmonary Fibrosis by Daoyin Technique
-
CLINICAL_TRIALS study record update · 2025-06-05Investigation of the Validity and Reliability of the Londrina Activities of Daily Living Protocol in Idiopathic Pulmonary Fibrosis Patients
-
CLINICAL_TRIALS study record update · 2025-05-30Phase 1b Double-Blind, Placebo-Controlled, Ascending Dose Trial: ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2025-05-29A Phase 2, Double-blind, Randomized, Placebo-controlled, Two-Treatment, Two-Period Crossover Efficacy and Safety Study in Idiopathic Pulmonary Fibrosis (IPF) With Nalbuphine ER Tablets for the Treatment of Cough
-
CLINICAL_TRIALS study record update · 2025-05-23A Phase 2, Multi-Centre, Open-Label, Single-Arm Trial Investigating the Safety, Efficacy and Pharmacokinetics of C21 in Subjects With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2025-05-14A Study of the Natural Progression of Interstitial Lung Disease (ILD)
-
CLINICAL_TRIALS study record update · 2025-04-30Influence of Coping Strategies on Short and Long-term Outcomes of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF) and Chronic Obstructive Pulmonary Disease (COPD)
-
CLINICAL_TRIALS study record update · 2025-04-25British Pigeon Fanciers Genetics of Interstitial Lung Disease Study
-
CLINICAL_TRIALS study record update · 2025-04-25End-expiratory Trans-pulmonary Pressure Guided PEEP Titration in Patients With Pulmonary Fibrosis and UIP Pattern Undergoing Mechanical Ventilation
-
CLINICAL_TRIALS study record update · 2025-04-25Inspiratory Effort and Respiratory Mechanics in Spontaneously Breathing Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Matched Control Study